Therapeutic Effects of Fenofibrate Nano-Emulsion Eye Drops on Retinal Vascular Leakage and Neovascularization

Therapeutic Effects of Fenofibrate Nano-Emulsion Eye Drops on Retinal Vascular Leakage and Neovascularization

Macular edema caused by retinal vascular leakage and ocular neovascularization are the leading causes of severe vision loss in diabetic retinopathy (DR) and age-related macular degeneration (AMD) patients. Oral administration of fenofibrate, a PPARα agonist, has shown therapeutic effects on macular...

Full description

Bibliographic Details
Main Authors:	Li Huang, Wentao Liang, Kelu Zhou, Ronald A. Wassel, Zachary D. Ridge, Jian-Xing Ma, Bing Wang
Format:	Article
Language:	English
Published:	MDPI AG 2021-12-01
Series:	Biology
Subjects:	fenofibrate nanomedicine eye drop age-related macular degeneration diabetic retinopathy PPARα
Online Access:	https://www.mdpi.com/2079-7737/10/12/1328

Similar Items

Fenofibrate Reduces the Severity of Neuroretinopathy in a Type 2 Model of Diabetes without Inducing Peroxisome Proliferator-Activated Receptor Alpha-Dependent Retinal Gene Expression
by: Jennifer M. Enright, et al.
Published: (2020-12-01)

Fenofibrate suppresses corneal neovascularization by regulating lipid metabolism through PPARα signaling pathway
by: Tong Zhou, et al.
Published: (2022-12-01)

Anti-inflammatory role of fenofibrate in treating diseases
by: Lv Jin, et al.
Published: (2023-05-01)

Effect of fenofibrate and selective PPARα modulator (SPPARMα), pemafibrate on KATP channel activity and insulin secretion
by: Shigeki Kitamura, et al.
Published: (2023-09-01)

A Fenofibrate Diet Prevents Paclitaxel-Induced Peripheral Neuropathy in Mice
by: Martial Caillaud, et al.
Published: (2020-12-01)

Fenofibrate for the prevention of progression of non-proliferative diabetic retinopathy: review, consensus recommendations and guidance for clinical practice
by: Nor Fariza Ngah, et al.
Published: (2022-12-01)

The case for intraocular delivery of PPAR agonists in the treatment of diabetic retinopathy
by: Treacy Maxwell P, et al.
Published: (2012-09-01)

Protective Effect of Fenofibrate on Oxidative Stress-Induced Apoptosis in Retinal–Choroidal Vascular Endothelial Cells: Implication for Diabetic Retinopathy Treatment
by: Ying-Jung Hsu, et al.
Published: (2020-08-01)

Fenofibrate inhibits TGF‐β‐induced myofibroblast differentiation and activation in human lung fibroblasts in vitro
by: Ryota Kikuchi, et al.
Published: (2021-08-01)

Comparison of efficacy and safety of choline fenofibrate (fenofibric acid) to micronized fenofibrate in patients of mixed dyslipidemia: A randomized, open-label, multicenter clinical trial in Indian population
by: Piyush Patel, et al.
Published: (2016-01-01)

Maillard Reaction Crosslinked Alginate-Albumin Scaffolds for Enhanced Fenofibrate Delivery to the Retina: A Promising Strategy to Treat RPE-Related Dysfunction
by: Maria Abedin Zadeh, et al.
Published: (2023-04-01)

Effect of fenofibrate on microcirculation and wound healing in healthy and diabetic mice
by: Valentin S, et al.
Published: (2009-02-01)

Fenofibrate in primary sclerosing cholangitis; a randomized, double‐blind, placebo‐controlled trial
by: Behzad Hatami, et al.
Published: (2022-08-01)

Association of Fenofibrate and Diabetic Retinopathy in Type 2 Diabetic Patients: A Population-Based Retrospective Cohort Study in Taiwan
by: Ying-Chieh Lin, et al.
Published: (2020-07-01)

Effect of fenofibrate on brain infarction, brain swelling and edema in focal-transient cerebral ischemia in rat
by: Hadi Vahidi, et al.
Published: (2021-10-01)

Development of Fenofibrate/Randomly Methylated β-Cyclodextrin-Loaded Eudragit<sup>®</sup> RL 100 Nanoparticles for Ocular Delivery
by: Soe Yadanar Khin, et al.
Published: (2022-07-01)

PPARα agonist fenofibrate prevents postoperative cognitive dysfunction by enhancing fatty acid oxidation in mice
by: Liu Tiantian, et al.
Published: (2023-11-01)

Fenofibrate Nano-Eyedrops Ameliorate Retinal Blood Flow Dysregulation and Neurovascular Coupling in Type 2 Diabetic Mice
by: Junya Hanaguri, et al.
Published: (2022-02-01)

Activation of PPARα by Fenofibrate Attenuates the Effect of Local Heart High Dose Irradiation on the Mouse Cardiac Proteome
by: Omid Azimzadeh, et al.
Published: (2021-12-01)

Fenofibrate Inhibits Subretinal Fibrosis Through Suppressing TGF‐β—Smad2/3 signaling and Wnt signaling in Neovascular Age‐Related Macular Degeneration
by: Qian Chen, et al.
Published: (2020-11-01)

Development and validation of bioanalytical UHPLC-UV method for simultaneous analysis of unchanged fenofibrate and its metabolite fenofibric acid in rat plasma: Application to pharmacokinetics
by: Rayan G. Alamri, et al.
Published: (2017-01-01)

Clickable corneal neovascularization therapy with ROS-responsive polydopamine silica nanoparticles loaded with fenofibrate
by: Kai Fan, et al.
Published: (2023-11-01)

Peroxisomal Fitness: A Potential Protective Mechanism of Fenofibrate against High Fat Diet-Induced Non-Alcoholic Fatty Liver Disease in Mice
by: Songling Jiang, et al.
Published: (2022-11-01)

Comparison of efficacy and safety of fixed dose combination of rosuvastatin and choline fenofibrate to fixed dose combination of rosuvastatin and fenofibrate in patients of mixed dyslipidemia: A randomized, open-label, multicentre clinical trial in Indian population
by: Hanmant Barkate, et al.
Published: (2018-01-01)

Efficacy and Safety of Fenofibrate in Patients with Hyperuricemia
by: Irfan Zafar, et al.
Published: (2012-04-01)

Efficacy and Safety of Fenofibrate in Patients with Hyperuricemia
by: Irfan Zafar, et al.
Published: (2012-04-01)

Fenofibrate-induced renal dysfunction, yes or no?
by: Fatemeh Emami, et al.
Published: (2020-01-01)

Intravitreal Ranibizumab for Subfoveal Choroidal Neovascularization from Age-Related Macular Degeneration with Combined Severe Diabetic Retinopathy
by: So Young Han, et al.
Published: (2015-02-01)

Fenofibrate Regulates Visceral Obesity and Nonalcoholic Steatohepatitis in Obese Female Ovariectomized C57BL/6J Mice
by: Yujin Shin, et al.
Published: (2021-04-01)

Role of fenofibrate in multiple sclerosis
by: Ahmad A. Abulaban, et al.
Published: (2024-02-01)

Effect of Fenofibrate on Neonatal Hyperbilirubinemia: A Systematic Review and Meta-analysis
by: Nasrin Zamiri-Miandoab, et al.
Published: (2021-07-01)

CLINICAL EFFICACY AND SAFETY OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR ALPHA AGONISTS IN RHEUMATOID ARTHRITIS: AN OPEN-LABEL CONTROLLED STUDY
by: V. S. Shirinsky, et al.
Published: (2014-07-01)

Targeting Peroxisome Proliferator Activated Receptor α (PPAR α) for the Prevention of Mitochondrial Impairment and Hypertrophy in Cardiomyocytes
by: Dipak Kar, et al.
Published: (2018-08-01)

Fenofibrate and Crataegus oxyacantha is an effectual combo for mixed dyslipidemia
by: Huda A Rasheed, et al.
Published: (2020-01-01)

Metabolomics in Retinal Diseases: An Update
by: Xing Li, et al.
Published: (2021-09-01)

Effects of fenofibrate in patients with type 2 diabetes mellitus complicated by diabetic neuropathy
by: Olga Nikolaevna Tkacheva, et al.
Published: (2010-03-01)

Oral fenofibrate for hyperbilirubinemia in term neonates: A single-blind randomized controlled trial
by: Seyed Hossein Saadat, et al.
Published: (2023-01-01)

A comparative study on the effects of niacin plus atorvastatin with that of fenofibrate plus atorvastatin in dyslipidemia
by: Selim Ahmed, et al.
Published: (2008-04-01)

A comparative study on the effects of niacin plus atorvastatin with that of fenofibrate plus atorvastatin in dyslipidemia
by: Salim Ahmed, et al.
Published: (2008-06-01)

A comparative study of efficacy of atorvastatin alone and its combination with fenofibrate on lipid profile in type 2 diabetes mellitus patients with hyperlipidemia
by: Meenakshi Lella, et al.
Published: (2013-01-01)